Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (3) | Back to Search
DDM-035 - Synthesis and characterization of surface modified and stimuli responsive mesoporous silica nanoparticles loaded with Epigallocatechin Gallate (EGCG) for drug delivery applications
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: DDM-035
- By: OKOROAFOR , Ureh Dibani (3, Nigeria)
- Co-author(s): Pharm Chioma C. Chukwunweike (1, Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences. University of Port Harcourt., Nigeria )
Professor Ken M. Ezealisiji (1, Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences. University of Port Harcourt., Nigeria )
Pharm Ureh Dibani Okoroafor (1, Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences. University of Port Harcourt., Nigeria )
Dr Xavier Siwe-Noundou (2, Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Box 218, MEDUNSA, Pretoria, 0204, South Africa)
Dr Madan S. Poka (2, Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Box 218, MEDUNSA, Pretoria, 0204, South Africa)
H.P Demana (2, Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Box 218, MEDUNSA, Pretoria, 0204, South Africa)
Prof Ogbona O. Okorie (3, Department of Pharmaceutics & Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Nigeria) - Abstract:
Nanotechnology has offered a more reliable alternative to achieving better treatment outcomes in disease management and diagnosis through the use of multifunctional biocompatible nanomaterials. For drug delivery purposes, the most widely studied nanomaterial is mesoporous silica nanoparticles (MSNs) which have been explored as an effective..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025